Overview
Gyros Protein Technologies provides automated nanoliter-scale immunoassays via Gyrolab systems for bioprocess analytics, including Protein A kits for residual ligand quantification and biomarker kits for cytokines. They offer peptide synthesizers, reagents, and purification solutions like PurePep EasyClean technology, partnered with Biotage for high-throughput automated peptide purification. These tools support drug discovery, development, and biotherapeutics manufacturing with high sensitivity, throughput, and reduced solvent use.
Frequently asked questions
- What are the key capabilities of Gyrolab immunoassay systems?
- Gyrolab systems enable automated nanoliter-scale immunoassays for Protein A quantification, biomarker analysis like cytokines (TNF-a, IFN-gamma, IL-6, IL-10, IL-4), and bioprocess analytics with high throughput, wide dynamic range, and minimal manual intervention.
- What peptide synthesis and purification solutions do they offer?
- They provide peptide synthesizers, reagents, and PurePep EasyClean (PEC) catch-and-release technology for automated high-throughput purification, integrated with Biotage Extrahera for up to 96 peptides in parallel, 75% faster and 98% lower solvent use than HPLC.
- What industries or applications do they serve?
- Gyros Protein Technologies serves pharmaceutical and biotech for drug discovery, biotherapeutics development, gene therapy bioprocess analytics, and peptide research, accelerating workflows from screening to large-scale production.